⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL270129 | 0.84 | — | — | |
| SCHEMBL29750174 | 0.81 | TP53 (0.38) | — | |
| Potassium SCHEMBL29750105 | 0.81 | TP53 (0.38) | — | |
| SCHEMBL16146089 | 0.81 | TP53 (0.38) | — | |
| SCHEMBL16146263 | 0.81 | TP53 (0.38) | — | |
| SCHEMBL16146087 | 0.81 | TP53 (0.38) | — | |
| Lithium SCHEMBL29750311 | 0.81 | TP53 (0.38) | — | |
| SCHEMBL503109 | 0.81 | TP53 (0.31) | — | |
| SCHEMBL2231969 | 0.81 | TP53 (0.31) | — | |
| SCHEMBL4120188 | 0.81 | LMNA (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2481423-A1 | Novel glycolipid adjuvant compositions | Pfizer Products Inc. (US) | 2012-08-01 | — | — | EP | claimed |
| JP-2009524638-A | — | — | 2009-07-02 | — | — | JP | claimed |
| CN-100441241-C | Crosslinked hyaluronic acid compositions for tissue augmentation | ANIKA THERAPEUTICS INC (US) | 2008-12-10 | — | — | CN | claimed |
| EP-1991266-A2 | NOVEL GLYCOLIPID ADJUVANT COMPOSITIONS | Pfizer Products Inc. (US) | 2008-11-19 | — | — | EP | claimed |
| US-20070196384-A1 | Novel glycolipid adjuvant compositions | ZOETIS SERVICES LLC | 2007-08-23 | — | — | US | claimed |
| WO-2007085962-A2 | NOVEL GLYCOLIPID ADJUVANT COMPOSITIONS | PFIZER PRODUCTS INC. (US) | 2007-08-02 | — | — | WO | claimed |
| CN-1893989-A | Crosslinked hyaluronic acid compositions for tissue augmentation | ANIKA THERAPEUTICS INC (US) | 2007-01-10 | — | — | CN | claimed |
| US-11541075-B2 | Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid | ANIKA THERAPEUTICS, INC. | 2023-01-03 | — | — | US | disclosed |
| US-10976319-B2 | Cell response assay for cancer and methods of producing and using same | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2021-04-13 | — | — | US | disclosed |
| CN-111567516-A | Semen diluent for improving fertilization rate of hatching eggs in later period of egg laying and application thereof | 扬州大学 | 2020-08-25 | — | — | CN | disclosed |
| US-20190339278-A1 | CELL RESPONSE ASSAY FOR CANCER AND METHODS OF PRODUCING AND USING SAME | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2019-11-07 | — | — | US | disclosed |
| EP-2748337-B1 | CELL RESPONSE ASSAY FOR CANCER AND METHODS OF PRODUCING AND USING SAME | SIEMENS HEALTHCARE DIAGNOSTICS INC (US) | 2019-08-07 | — | — | EP | disclosed |
| EP-2691534-B1 | ADIPONECTIN RECEPTOR C-TERMINAL FRAGMENTS (CTF)-IMMUNOGLOBULIN | SIEMENS HEALTHCARE DIAGNOSTICS INC (US) | 2017-07-26 | — | — | EP | disclosed |
| WO-2007085962-A2 | NOVEL GLYCOLIPID ADJUVANT COMPOSITIONS | PFIZER PRODUCTS INC. (US) | 2007-08-02 | — | — | WO | disclosed |
| CN-1893989-A | Crosslinked hyaluronic acid compositions for tissue augmentation | ANIKA THERAPEUTICS INC (US) | 2007-01-10 | — | — | CN | disclosed |
| CN-1816573-A | (N-vinylamide) polymers and copolymers and their use in capillary electrophoresis | APPLERA CORP (US) | 2006-08-09 | — | — | CN | disclosed |
| CN-1696109-A | Derivative of substitutional taurine and preparation method | UNIV BEIJING (CN) | 2005-11-16 | — | — | CN | disclosed |
| US-5916426-A | UNCHARGED WATER-SOLUBLE SILICA ABSORBING POLYMERS; FOR SEPARATING POLYNUCLEOTIDES | THE PERKIN-ELMER CORPORATION (US) | 1999-06-29 | — | — | US | disclosed |
| EP-0792146-A1 | INACTIVATION OF PATHOGENS USING HYDROXYMETHYLAMINES | HEMASURE, INC. (US) | 1997-09-03 | — | — | EP | disclosed |
| WO-1997002028-A1 | INACTIVATION OF PATHOGENS USING HYDROXYMETHYLAMINES | HEMASURE, INC. (US) | 1997-01-23 | — | — | WO | disclosed |